Arrowhead Pharmaceuticals (ARWR) had the lowest return in 2016 by a large-cap US stock, returning -74%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Arrowhead Pharmaceuticals (ARWR) | 2016 | -74.04% |
Alnylam Pharmaceuticals (ALNY) | 2016 | -59.38% |
First Solar (FSLR) | 2016 | -50.41% |
Tenet Healthcare (THC) | 2016 | -49.28% |
Teva Pharma Industries Ltd ADR (TEVA) | 2016 | -42.1% |
Vertex Pharmaceuticals (VRTX) | 2016 | -40.12% |
Novo Nordisk A-S (NVO) | 2016 | -36.25% |
Telefonaktiebolaget LM Ericsson B ADR (ERIC) | 2016 | -35.99% |
Natwest (NWG) | 2016 | -35.85% |
Jones Lang LaSalle (JLL) | 2016 | -35.43% |
Embraer (EMBJ) | 2016 | -34.53% |
ZTO Express (Cayman) (ZTO) | 2016 | -34.4% |
Illumina (ILMN) | 2016 | -31.77% |
Regeneron Pharmaceuticals (REGN) | 2016 | -30.97% |
Neurocrine Biosciences (NBIX) | 2016 | -30.02% |
Axsome Therapeutics (AXSM) | 2016 | -29.25% |
Nokia (NOK) | 2016 | -28.75% |
Viatris (VTRS) | 2016 | -27.86% |
Palo Alto Networks (PANW) | 2016 | -27.7% |
McKesson (MCK) | 2016 | -26.95% |
Gilead Sciences (GILD) | 2016 | -26.56% |
Everpure (P) | 2016 | -26.27% |
DexCom (DXCM) | 2016 | -25.64% |
Insmed (INSM) | 2016 | -25.3% |
Virtu Financial (VIRT) | 2016 | -24.82% |
Large-cap stocks are treated as having a market cap of $10B+.